Tag: COVID-19 antigen test

Why Did the UK Government Waste £4 Billion on the Innova Lateral Flow Test?

June 22, 2023
COVID-19 antigen testUncategorized
0 Comment

Today is the first day of the multi-million pound COVID-19 Inquiry set up to “examine the UK’s response to and impact of the Covid-19 pandemic, and learn lessons for the future.” The irony is that one of the most important questions centered around the UK’s COVID-19 response will probably never be asked by the inquiry committee—why the…

Read More

Chinese Officials Profiteering From Overpriced COVID-19 Test Kits

March 26, 2022
CCP VirusCOVID-19 antigen testCOVID-19 test kitsINSIDE CHINAmass testing
0 Comment

Since the Omicron variant outbreak began in China, Chinese state-owned companies have been making billions of dollars selling test kits to the public. The rapid antigen detection tests approved by Chinese authorities for home use are selling at many times the cost of manufacturing. As the competition among Chinese manufacturers has intensified, the cost of…

Read More

Rapid Home COVID Antigen Tests May Have Severe Limitations

March 23, 2022
COVID-19 antigen testOpinionViewpoints
0 Comment

Commentary Many millions of these rapid antigen tests at a cost of billions of dollars are now in most homes. The federal government and many local organizations have been making them available without charge. But newly published research from the UK sheds a dark shadow on their usefulness. The initial hope was that making rapid…

Read More

British Company Pulls COVID-19 Testing Product Off Market Following Drop in Effectiveness

January 11, 2022
Business & EconomyBusinesses in COVID-19CCP VirusCompaniesCOVID-19 antigen testOmicron variantrapid antigen testingUKWorld
0 Comment

Britain’s Avacta Group has temporarily halted sales of its COVID-19 lateral flow test, according to a statement released Monday, in order to replace the antibody in the device and ensure that the effectiveness of detecting the Omicron variant is on par with that of previous strains. Avacta, based in Cambridge, has since lost a third…

Read More